summary: This preliminary study investigated the tolerability and safety of daclizumab, a new experimental treatment proposed for use in severe MS. As with other antibody treatments like natalizumab there were some important side effects, in this case cardiotoxicity and viral meningitis. Further studies are needed to see if this medication will be useful.

authors: Ali E, Healy B, Stazzone L, Brown B, Weiner H, Khoury S

source: Mult Scler. 2009 Jan 9. [Epub ahead of print]

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: